Company intelligence
Emergent BioSolutions
We help prepare for today's challenges and tomorrow's threats.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud
Verified activity
Signals from Emergent BioSolutions
5 published signals
Capital & Finance
Emergent BioSolutions completed the repurchase of $75 million aggregate principal amount of senior unsecured notes.
Reported by Emergent BioSolutions
Presence & Recognition
Emergent BioSolutions featured Dr. Paul Keim, Dr. Daniel Lucey, and Dr. Asha M. George in the newest episode of Countermeasures discussing the anthrax attacks and their legacy in biodefense, health preparedness, and national security.
Reported by Emergent BioSolutions
Presence & Recognition
Emergent BioSolutions attended an event held by the Pennsylvania Department of Drug and Alcohol Programs to recognize International Overdose Awareness Day and the one-year milestone of Philadelphia’s Naloxone in Black initiative.
Reported by Emergent BioSolutions
Partnerships
Emergent BioSolutions was awarded a contract modification valued at approximately $24 million from the U.S. government to supply CYFENDUS.
Reported by Emergent BioSolutions
Partnerships
Emergent BioSolutions was awarded a standing offer by the Government of Canada through a competitive procurement process to supply NARCAN Nasal Spray.
Reported by Emergent BioSolutions